Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ATR inhibitor 2 is an orally active, ATP-competitive, and selective ATR inhibitor (Ki <150 pM) with antitumor activity. ATR inhibitor 2 potently inhibits ATR-driven phosphorylated checkpoint kinase-1 (Chk1) phosphorylation (IC50: 8 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,200.00 | |
50 mg | 6-8 weeks | $ 1,570.00 | |
100 mg | 6-8 weeks | $ 2,360.00 |
Description | ATR inhibitor 2 is an orally active, ATP-competitive, and selective ATR inhibitor (Ki <150 pM) with antitumor activity. ATR inhibitor 2 potently inhibits ATR-driven phosphorylated checkpoint kinase-1 (Chk1) phosphorylation (IC50: 8 nM). |
Targets&IC50 | ATR:150 pM (ki) |
In vivo | In monotherapy efficacy studies ATR inhibitor 2 (VX-970, M6620) shows tumor stasis to regression in tumor models with alternative lengthening of telomeres (ALT). |
Synonyms | ATR inhibitor 2 |
Molecular Weight | 541.55 |
Formula | C25H29F2N9O3 |
CAS No. | 1613191-99-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gartisertib 1613191-99-3 DNA Damage/DNA Repair PI3K/Akt/mTOR signaling ATM/ATR ATR inhibitor 2 inhibitor inhibit